Barclays
GUTS icon

Barclays’s Fractyl Health GUTS Stock Holding History

Barclays’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.1K Sell
116,048
-127,246
-52% -$117K ﹤0.01% 4297
2025
Q4 		$535K Buy
+243,294
New +$392K ﹤0.01% 3807
2025
Q2 		– Sell
-35,907
Closed -$42.7K – 5596
2025
Q1 		$42.7K Sell
35,907
-17,019
-32% -$27.2K ﹤0.01% 4655
2024
Q4 		$109K Buy
52,926
+5,130
+11% +$11.9K ﹤0.01% 4571
2024
Q3 		$121K Buy
47,796
+45,219
+1,755% +$148K ﹤0.01% 4519
2024
Q2 		$11K Buy
+2,577
New +$16.6K ﹤0.01% 4510

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays's GUTS Position: Q1 2026 in Review

Barclays reduced its Fractyl Health (GUTS) stake by 52% in Q1 2026, selling an estimated $117K and leaving 116,048 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4297.

Barclays first reported a position in GUTS in Q2 2024 and has held it in 6 quarters since. The position peaked at $535K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Barclays held 116,048 shares of Fractyl Health worth $53.1K as of Q1 2026.
  • Barclays sold 127,246 Fractyl Health shares in Q1 2026, an estimated $117K.
  • Fractyl Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4297 holding.
  • Barclays first reported a position in Fractyl Health in Q2 2024 and has held it in 6 quarters since.
  • Barclays's Fractyl Health position peaked at $535K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.